Home › Bids
› Forecast for HEAL Initiative: Non-addictive Analgesic Therap
Forecast for HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional
This is a funding opportunity (grant) from the NIH HEAL Initiative for developing non-addictive analgesic therapeutics (small molecules and biologics) to treat pain. The grant mechanism is UG3/UH3, with an optional clinical trial component.
Line Items
Item
Qty
Unit
Est. Unit Price
Est. Total
Category
Non-addictive Analgesic Therapeutics Development (Small Molecules)
1
project
$2,500,000.00
$2,500,000.00
Medical
Non-addictive Analgesic Therapeutics Development (Biologics)
1
project
$2,500,000.00
$2,500,000.00
Medical
Clinical Trial (Optional) for Non-addictive Analgesic Therapeutics
1
trial
$5,000,000.00
$5,000,000.00
Medical
Estimated Bid Value
$10,000,000.00
Want the full details?
Sign up free to see the agency name, contact info, and the original bid posting link.